KRAS and colorectal carcinoma: If CTH rs1021737 variant carriers do have decreased enzyme activity, then a role for H2S in preventing KRAS-mutated CRC and promoting BRAF-mutated CRC would be consistent with our observations for the rs1021737 SNP in the NSHDS.